A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

BACKGROUND: Treatment with epidermal growth factor receptor (EGFR) inhibitors can result in clinical response in non-small-cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) for some unselected patients. EGFR and KRAS mutation status, amplification of EGFR, or gene expression predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, J L, Britson, J, Balko, J M, Willian, M, Timmons, R, Frolov, A, Black, E P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251842/
https://www.ncbi.nlm.nih.gov/pubmed/22045191
http://dx.doi.org/10.1038/bjc.2011.465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251842/
https://www.ncbi.nlm.nih.gov/pubmed/22045191
http://dx.doi.org/10.1038/bjc.2011.465

Ejemplares similares